Category: FDA

2 7/11/2017

Fact-checking pharma: 5 cancer drug myths, busted

1 1/26/2017

Approval of ‘breakthrough’ hepatitis C drugs isn’t even half the story; now come the harms

1/9/2017

Whitewashing a black box warning: The Chantix story that didn’t get told

11 12/6/2016

With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line

1 11/29/2016

Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?

10/31/2016

Early report card on quality of FDA news releases: C at best

10/25/2016

Black box warnings for ‘lifesaving’ hepatitis C drugs highlight systematic misinformation

3 9/28/2016

What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups

3 6/22/2016

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

6/13/2016

21st Century Cures Act nears passage with little news media scrutiny

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

ScienceWriters @ScienceWriters·

A guide to specificity, sensitivity, positive predictive value, and other medical testing concepts. https://t.co/wDwTktPiWg @HealthNewsRevu

Reply on Twitter Retweet on Twitter7 Like on Twitter6 Twitter

Retweet on Twitter HealthNewsReview.org Retweeted

Marc Gozlan @MarcGozlan·

.@HealthNewsRevu, qui annonce son arrêt en décembre prochain après 12 ans d'activité. Ce site, véritable chien de garde de l'info santé, n'a eu de cesse de lutter contre la mésinformation, la désinformation et les conflits d'intérêt dans le journalisme médico-scientifique.

Reply on Twitter Retweet on Twitter3 Like on Twitter5 Twitter

Retweet on Twitter HealthNewsReview.org Retweeted

David Grenache, PhD @ClinChemDoc·

Thank you, thank you, thank you, @HealthNewsRevu for this piece! Required reading for anyone who has ever had or ordered a lab test. So, basically, everyone. Understanding medical tests: sensitivity, specificity, and positive predictive value https://t.co/BRt3qJLKgo

Reply on Twitter Retweet on Twitter13 Like on Twitter17 Twitter

Category: FDA

Fact-checking pharma: 5 cancer drug myths, busted

Approval of ‘breakthrough’ hepatitis C drugs isn’t even half the story; now come the harms

Whitewashing a black box warning: The Chantix story that didn’t get told

With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line

Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?

Early report card on quality of FDA news releases: C at best

Black box warnings for ‘lifesaving’ hepatitis C drugs highlight systematic misinformation

What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

21st Century Cures Act nears passage with little news media scrutiny

Blog

Categories

Tags

@HealthNewsRevu